Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1200 participants.

Also called NCT01819441

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,200 participants (planned count) (from the registry)
Sponsor
Yining Huang (from the registry)
Registry
  • NCT NCT01819441
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01819441. Randomized; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients
Acronym
APPROVE
Condition
Cerebral Small Vessel Diseases
Intervention (Drug)
Azelnidipine
Intervention (Drug)
Perindopril
Intervention (Drug)
hydrochlorothiazide
Lead sponsor
Yining Huang (class: other)

Record details

Record id
cardio:ct-nct01819441
Content hash
945827127f7d8951a1a04d563cc0b4451480573b8b68c47d32586fd9ff19d130